Status:Closed

Opening date: 15 September 2025

Closing date: 3 November 2025

Collaborative action Academic Resarch/Patient Organisation (NPO)

To encourage collaborative projects between MarMaRa Institute teams and patient associations, the Institute has launched a specific call for tenders for the first time in 2022. The aim is to strengthen links between research teams and patients through co-financing.

Each project is financed by the institute and the association, with a maximum of €10,000 for MarMaRa and an amount from the association equal to or greater than that of the institute (for example: €5,000 institute and €5,000 association; €7,000 institute and €7,000 association; €10,000 institute and €12,000 association). The maximum duration is 24 months.

Year

Title

Partners

Budget and duration

Link to research team

Link to the association
2025
2024 New therapeutic perspectives for CCHS This project is led by Jean-Charles Viemari (MMG laboratory) and the AFSO association. Budget: €20,000 (€10,000 institute and €10,000 association)
Duration: 18 months		 https://www.marseille-medical-genetics.org/fr/l-villard/ AFSO
2023 Long read Sequencing to reduce diagnosis deadlocks in patients clinically diagnosed with FacioScapuloHumeral Dystrophy This project is led by Frédérique Magdinier (MMG laboratory) and the AMIS FSH association. Budget: €25,500 (€10,500 institute and €15,000 association)
Duration: 24 months.		 https://www.marseille-medical-genetics.org/fr/f-magdinier/ AMIS FSH
2022 Modelling Laminin a2-deficiency congenital muscular dystrophy using patients' pluripotent stem cells This project is led by Leslie Caron (MMG laboratory) and the LAMA2France association. Budget: €20,000 (€10,000 institute and €10,000 association)
Duration: 24 months.		 https://www.marseille-medical-genetics.org/fr/f-magdinier/ LAMA2
2022 Spatial transcriptomic profiling of a rare somatic RASopathy This project is led by Heather Etchevers (MMG laboratory) and the association Naevus 2000 France Europe. Budget:€11,000 (€5,500 institute and €5,500 association)
Duration: 12 months.		 https://www.marseille-medical-genetics.org/fr/h-etchevers/ NAEVUS 2000

Documents

Marie-Cécile
Gaillard
Project officer, Scientific Referent
MMG Marseille Medical Genetics, MarMaRa office - Campus Marseille Timone
marie-cecile.gaillard@univ-amu.fr
Céline Damon
President of the LAMA2-France association / Winner of the "laboratory/association collaborative project" call, 2022
The aim of our project is to develop and study new cellular models of LAMA2-RD derived from patient stem cells (hiPSC). Thanks to this funding, the team has already derived hiPSCs from four patients carrying different mutations in the LAMA2 gene, and phenotypic analyses of the differentiated muscle cells are currently underway. These will enable us to identify the pathological mechanisms of LAMA2-RD in humans and new therapeutic targets.For our small LAMA2 France association, our priority is to be able to provide practical support to researcher [...]